Beijing Strong BiotechnologiesInc Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Beijing Strong BiotechnologiesInc has a total shareholder equity of CN¥4.0B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are CN¥5.5B and CN¥1.5B respectively. Beijing Strong BiotechnologiesInc's EBIT is CN¥639.4M making its interest coverage ratio 28.3. It has cash and short-term investments of CN¥994.6M.
Anahtar bilgiler
29.4%
Borç/özkaynak oranı
CN¥1.17b
Borç
| Faiz karşılama oranı | 28.3x |
| Nakit | CN¥994.56m |
| Eşitlik | CN¥3.96b |
| Toplam yükümlülükler | CN¥1.49b |
| Toplam varlıklar | CN¥5.46b |
Son finansal sağlık güncellemeleri
Recent updates
Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?
Jul 25
Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price
Jul 03An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued
Jun 14Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?
Mar 21Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified
Mar 03Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)
Feb 27Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 300406's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥287.6M).
Uzun Vadeli Yükümlülükler: 300406's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥1.2B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 300406's net debt to equity ratio (4.3%) is considered satisfactory.
Borcun Azaltılması: 300406's debt to equity ratio has increased from 0% to 29.4% over the past 5 years.
Borç Kapsamı: 300406's debt is well covered by operating cash flow (53.3%).
Faiz Kapsamı: 300406's interest payments on its debt are well covered by EBIT (28.3x coverage).